TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$241M, a 10.1% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.02B, a 0.49% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2023 was -$1.06B, a 9.42% decline from 2022.
  • Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2022 was -$966M, a 8.7% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2021 was -$1.06B, a 26.9% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.06B -$91M -9.42% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 -$966M +$92M +8.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 -$1.06B -$224M -26.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 -$834M -$12M -1.46% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$822M +$137M +14.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 -$959M -$64M -7.15% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 -$895M +$435M +32.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 -$1.33B -$330M -33% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 -$1B -$687M -219% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 -$313M +$86M +21.6% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 -$399M -$13M -3.37% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 -$386M -$233M -152% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 -$153M +$72M +32% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 -$225M Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.